Eva Kassi results 3
· Newest (Page 1/1, per page 25)
Author: Eva Kassi ×Clear All Filters
Search Results
The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative reviewNARA Subscribed
Purpose Non-alcoholic fatty liver disease (NAFLD) has become a leading cause of liver disease, affecting 30% of the global population. NAFLD prevalence is particularly high in obese individuals and patients with type 2 diabetes mellitus (T2DM). NAFLD ranges from simple fat deposition in the liver to necroinflammation and fibrosis (non-alcoholic steatohepatitis (NASH)), NASH-cirrhosis, and/or hepatocellular carcinoma. Insulin r...
Previous1Next